Medicine
 |
|
3 july 2020 21:50:10 |
| ICON: a randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer (Journal of Translational Medicine) |
|
Tweet Immunotherapy with checkpoint inhibitors (CPI) targeting PD-1 or CTLA-4 has emerged as an important treatment modality for several cancer forms. In hormone receptor positive breast cancer (HR + BC), this thera... |
| 359 viewsCategory: Medicine |
 The timeline and risk factors of clinical progression of COVID-19 in Shenzhen, China (Journal of Translational Medicine)Agreement between original and Rasch-approved neck disability index (BMC Medical Research Methodology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
